Research graph
References from Progress on the regulation of colorectal cancer and cardio-oncology by the gut microbiota and nutrients. Local targets link to admitted publications; unresolved targets remain external evidence.
Dietary modulation of gut microbiota in patients with colorectal cancer undergoing surgery: A review
10.1016/j.ijsu.2022.106751 · 2022 · External reference
Mechanisms of intestinal flora in colorectal cancer
10.1093/postmj/qgaf026 · 2025 · External reference
Gut microbiota dysbiosis drives the development of colorectal cancer
10.1159/000508328 · 2021 · External reference
Gut microbiota, inflammatory bowel disease and colorectal cancer
10.3748/wjg.v28.i30.4053 · 2022 · External reference
Colorectal cancer occurrence and treatment based on changes in intestinal flora
10.1016/j.semcancer.2020.05.004 · 2021 · External reference
Association analysis of the differences in intestinal flora and clinical tumor indicators among colorectal cancer patients
10.3389/fcimb.2026.1742672 · 2026 · External reference
Gut microbiota and colorectal cancer metastasis
10.1016/j.canlet.2022.216039 · 2023 · External reference
Gut microbiota in colorectal cancer development and therapy
10.1038/s41571-023-00766-x · 2023 · External reference
Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer
10.1016/j.ccell.2022.11.013 · 2023 · External reference
Gut microbiota-associated predictors as biomarkers of neoadjuvant treatment response in rectal cancer-a systematic review
10.1038/s41416-026-03443-9 · 2026 · External reference
A novel radio-immunotherapy strategy: Gut microbiota metabolite combined with radioactive hydrogel for the treatment of low rectal cancer
10.1016/j.biomaterials.2025.123386 · 2025 · External reference
The obesity-related gut bacterial and viral dysbiosis can impact the risk of colon cancer development
10.3390/microorganisms8030431 · 2020 · External reference
Gut microbiota and colorectal cancer risk factors
10.2174/1389201023666221005103340 · 2023 · External reference
Dietary manipulation on gut microbiome in patients with diabetes and colorectal cancer
10.1007/s13668-025-00667-8 · 2025 · External reference
Association of anti-inflammatory dietary adherence with biomarkers and gut microbiota related to colorectal cancer risk: A retrospective study
10.1002/fsn3.71497 · 2026 · External reference
Calorie restriction remodels gut microbiota and suppresses tumorigenesis of colorectal cancer in mice
10.3892/etm.2022.11758 · 2023 · External reference
High-fat diet-induced gut microbiota disruption promotes colorectal cancer lymphatic metastasis via propionate/GPR41 signaling
10.1159/000545843 · 2025 · External reference
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
10.1016/j.annonc.2019.10.023 · 2020 · External reference
Coronary atherosclerosis in patients with cancer and survivors: A scientific statement from the American Heart Association
10.1161/cir.0000000000001391 · 2026 · External reference
Oxaliplatin-induced acquired long QT syndrome with torsades de pointes and myocardial injury in a patient with dilated cardiomyopathy and rectal cancer
10.1016/j.jcma.2013.05.001 · 2013 · External reference
Consequences of ionizing radiation exposure to the cardiovascular system
10.1038/s41569-024-01056-4 · 2024 · External reference
Interplay between gut microbiota and cholesterol metabolism in colorectal cancer
10.3390/ijms27062553 · 2026 · External reference
Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice
10.1016/j.intimp.2020.106862 · 2020 · External reference
Polysaccharide of Danggui Buxue Decoction attenuates colorectal cancer via modulating intestinal microflora and metabolites
10.1007/s11655-025-3833-x · 2026 · External reference
AC1Q3QWB inhibits colorectal cancer progression by modulating the immune response and balancing the structure of the intestinal microbiota
10.1016/j.intimp.2023.109768 · 2023 · External reference
Intestinal dysbiosis and colorectal cancer
10.1097/cm9.0000000000003617 · 2025 · External reference
Effect of gut microbiota in the colorectal cancer and potential target therapy
10.1007/s12672-022-00517-x · 2022 · External reference
Biological mechanisms of enterotoxigenic Bacteroides fragilis toxin: Linking inflammation, colorectal cancer, and clinical implications
10.3390/toxins17060305 · 2025 · External reference
Downregulation of the farnesoid X receptor promotes colorectal tumorigenesis by facilitating enterotoxigenic Bacteroides fragilis colonization
10.1016/j.phrs.2022.106101 · 2022 · External reference
Caffeic acid phenethyl ester administration reduces enterotoxigenic Bacteroides fragilis-induced colitis and tumorigenesis
10.3390/toxins16090403 · 2024 · External reference
Enterotoxigenic Bacteroides fragilis induces the stemness in colorectal cancer via upregulating histone demethylase JMJD2B
10.1080/19490976.2020.1788900 · 2020 · External reference
Enterotoxigenic Bacteroides fragilis (ETBF) enhances colorectal cancer cell proliferation and metastasis through HDAC3/miR-139-3p pathway
10.1007/s10528-023-10621-4 · 2024 · External reference
The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review
10.1186/s12935-021-01886-z · 2021 · External reference
Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming
10.1371/journal.pone.0297897 · 2024 · External reference
The microbiome types of colorectal tissue are potentially associated with the prognosis of patients with colorectal cancer
10.3389/fmicb.2023.1100873 · 2023 · External reference
Association of enterotoxigenic Bacteroides fragilis with immune modulation in colorectal cancer liver metastasis
10.3390/cancers17172733 · 2025 · External reference
Tumor-promoting gut microbes in colorectal cancer: Mechanisms and translational perspectives
10.7150/ijms.123494 · 2026 · External reference
Prevalence of pks + bacteria and enterotoxigenic Bacteroides fragilis in patients with colorectal cancer
10.1186/s13099-022-00523-y · 2022 · External reference
Intratumoral presence of the genotoxic gut bacteria pks(+) E. coli, enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer
10.1038/s41416-023-02554-x · 2024 · External reference
Gut microbiome as a treatment in colorectal cancer
10.1080/08830185.2024.2312294 · 2024 · External reference
Potential role of the gut microbiome in colorectal cancer progression
10.3389/fimmu.2021.807648 · 2021 · External reference
Impeding quorum sensing among the intestinal microbiota impacts the metastatic rate of colorectal cancer
10.1002/cam4.71009 · 2025 · External reference
Male-biased gut microbiome and metabolites aggravate colorectal cancer development
10.1002/advs.202206238 · 2023 · External reference
Changes in gut microbiome upon orchiectomy and testosterone administration in AOM/DSS-induced colon cancer mouse model
10.4143/crt.2022.080 · 2023 · External reference
Gut microbiota, epigenetic modification and colorectal cancer
2017 · External reference
Advances in gut microbiota-related treatment strategies for managing colorectal cancer in humans
10.20892/j.issn.2095-3941.2024.0263 · 2025 · External reference
Modulation of the tumor microenvironment by microbiota-derived short-chain fatty acids: Impact in colorectal cancer therapy
10.3390/ijms24065069 · 2023 · External reference
Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation
10.1016/j.canlet.2021.11.027 · 2022 · External reference
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention
10.1080/19490976.2025.2483780 · 2025 · External reference
Fecal short-chain fatty acids in colorectal cancer patients versus healthy controls: A systematic review and meta-analysis
10.3390/jcm14248949 · 2025 · External reference
Short-chain fatty acids and colorectal cancer: A systematic review and integrative Bayesian meta-analysis of microbiome-metabolome interactions and intervention efficacy
10.3390/nu17223552 · 2025 · External reference
Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer
10.7150/thno.54476 · 2021 · External reference
Inulin modulates gut microbiota and increases short-chain fatty acids levels to inhibit colon tumorigenesis in rat models: A systematic review and meta-analysis
10.1111/1750-3841.70250 · 2025 · External reference
The metabolism-immune axis in colorectal cancer: Remodeling the tumor microenvironment through metabolite signaling
10.3389/fimmu.2025.1735873 · 2025 · External reference
Ginseng polysaccharides ameliorate colorectal tumorigenesis through Lachnospiraceae-mediated immune modulation
10.1016/j.ijbiomac.2025.142015 · 2025 · External reference
Zhenqi Fuzheng Granule targets the SCFAs-GPR109A axis to enhance PD-1 antibody efficacy via immunometabolic remodeling in colorectal cancer
10.1016/j.phymed.2025.157312 · 2025 · External reference
Research progress on gut microbiota in colorectal cancer immunotherapy
10.1016/j.bbcan.2025.189476 · 2025 · External reference
Gut-microbiota-derived metabolites and probiotic strategies in colorectal cancer: Implications for disease modulation and precision therapy
10.3390/nu17152501 · 2025 · External reference
Gut microbiome diagnostic biomarkers for colorectal cancer
10.5152/tjg.2025.24810 · 2025 · External reference
Colorectal cancer and gut microbiota studies in China
10.1080/19490976.2023.2236364 · 2023 · External reference
Salivary and fecal microbiota: Potential new biomarkers for early screening of colorectal polyps
10.3389/fmicb.2023.1182346 · 2023 · External reference
Cost effectiveness of colorectal cancer screening strategies in middle- and high-income countries: A systematic review
10.1111/jgh.16882 · 2025 · External reference
Altered mycobiota signatures and enriched pathogenic Aspergillus rambellii are associated with colorectal cancer based on multicohort fecal metagenomic analyses
10.1053/j.gastro.2022.06.038 · 2022 · External reference
BRAF(V600E) mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies
10.1186/s13046-020-01801-w · 2020 · External reference
Fecal bacterial biomarkers and blood biochemical indicators as potential key factors in the development of colorectal cancer
10.1128/msystems.00043-25 · 2025 · External reference
The comparison of fecal microbiota in left-side and right-side human colorectal cancer
10.1159/000516922 · 2021 · External reference
Enterotypical Prevotella and three novel bacterial biomarkers in preoperative stool predict the clinical outcome of colorectal cancer
10.1186/s40168-022-01388-8 · 2022 · External reference
Microbe-based management for colorectal cancer
10.1097/cm9.0000000000001887 · 2021 · External reference
The impact of the microbiota on the immune response modulation in colorectal cancer
10.3390/biom15071005 · 2025 · External reference
Gut microbiota and colorectal cancer: A balance between risk and protection
10.3390/ijms26083733 · 2025 · External reference
The beneficial effect of probiotics in the prevention of irinotecan-induced diarrhea in colorectal cancer patients with colostomy: A pooled analysis of two probiotic trials (Probio-SK-003 and Probio-SK-005) led by Slovak Cooperative Oncology Group
10.3389/fonc.2024.1438657 · 2024 · External reference
Targeted depletion of pks+ bacteria from a fecal microbiota using specific antibodies
10.1128/msystems.00079-23 · 2023 · External reference
Gut microbiome-driven colorectal cancer via immune, metabolic, neural, and endocrine axes reprogramming
10.1038/s41522-025-00883-8 · 2026 · External reference
Harnessing gut microbiota for colorectal cancer therapy: From clinical insights to therapeutic innovations
10.1038/s41522-025-00818-3 · 2025 · External reference
Chronic antibiotic use, gut microbiota dysbiosis, and increased risk of colorectal cancer: An emerging threat
10.1002/hsr2.71866 · 2026 · External reference
Integrated gut microbiome and metabolome analysis reveals the inhibition effect of Lactobacillus plantarum CBT against colorectal cancer
10.1039/d3fo04806c · 2024 · External reference
Short-chain fatty acids play a positive role in colorectal cancer
10.1007/s12672-024-01313-5 · 2024 · External reference
Microbiota-derived short-chain fatty acids: New road in colorectal cancer therapy
10.3390/pharmaceutics14112359 · 2022 · External reference
Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression
10.1038/s42255-024-01191-9 · 2025 · External reference
Colorectal cancer and microbiota: Systematic review
10.5114/pg.2024.136228 · 2024 · External reference
Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient-derived organoids
10.3892/ijo.2020.5132 · 2020 · External reference
Prospective associations of circulating bile acids and short-chain fatty acids with incident colorectal cancer
10.1093/jncics/pkac027 · 2022 · External reference
Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer
10.1002/advs.202205563 · 2023 · External reference
High soluble fiber promotes colorectal tumorigenesis through modulating gut microbiota and metabolites in mice
10.1053/j.gastro.2023.10.012 · 2024 · External reference
Exploring the role of gut microbiome in colon cancer
10.1007/s12010-021-03498-9 · 2021 · External reference
Physiological drivers of pks+ E. coli in colorectal cancer
10.1016/j.tim.2025.04.010 · 2025 · External reference
Contribution of pks+ Escherichia coli (E. coli) to colon carcinogenesis
10.3390/microorganisms12061111 · 2024 · External reference
Crosstalk between gut microbiota and metastasis in colorectal cancer: Implication of neutrophil extracellular traps
10.3389/fimmu.2023.1296783 · 2023 · External reference
Characterization of the gut microbiota in patients with stage III colorectal cancer: A case-control study
10.1016/j.gene.2025.149913 · 2026 · External reference
Diversity in gut microbiota among colorectal cancer patients: Findings from a case-control study conducted at a Tunisian University Hospital
10.1007/s12672-024-01232-5 · 2024 · External reference
Gut microbiota-derived metabolites in CRC progression and causation
10.1007/s00432-021-03729-w · 2021 · External reference
The effect of haem in red and processed meat on the endogenous formation of N-nitroso compounds in the upper gastrointestinal tract
10.1093/carcin/bgl192 · 2007 · External reference
Alterations in the gut microbiota and their metabolites in colorectal cancer: Recent progress and future prospects
10.3389/fonc.2022.841552 · 2022 · External reference
Curcumin suppresses colorectal tumorigenesis through restoring the gut microbiota and metabolites
10.1186/s12885-024-12898-z · 2024 · External reference
Microbiota-associated mechanisms in colorectal cancer
10.1016/bs.adgen.2024.05.002 · 2024 · External reference
Hydrogen sulfide perturbs mitochondrial bioenergetics and triggers metabolic reprogramming in colon cells
10.1074/jbc.ra119.009442 · 2019 · External reference
Production of hydrogen sulfide by the intestinal microbiota and epithelial cells and consequences for the colonic and rectal mucosa
10.1152/ajpgi.00261.2020 · 2021 · External reference
Implications of hydrogen sulfide in colorectal cancer: Mechanistic insights and diagnostic and therapeutic strategies
10.1016/j.redox.2023.102601 · 2023 · External reference
Resistant starch nanoparticles induce colitis through lysosomal exocytosis in mice
10.1021/acsnano.4c10481 · 2024 · External reference
Amelioration impact of gut-brain communication on obesity control by regulating gut microbiota composition through the ingestion of animal-plant-derived peptides and dietary fiber: Can food reward effect as a hidden regulator
10.1080/10408398.2023.2241078 · 2024 · External reference
Post-diagnostic ultra-processed food exposure in gastrointestinal cancers: scoping review with narrative synthesis and clinical implications
10.3389/fnut.2026.1884359 · 2026 · External reference
Fusobacterium nucleatum induces chemoresistance in colorectal cancer by inhibiting pyroptosis via the Hippo pathway
10.1080/19490976.2024.2333790 · 2024 · External reference
Tea polyphenols inhibit the growth and virulence properties of Fusobacterium nucleatum
10.1038/srep44815 · 2017 · External reference
Interplay between dietary polyphenols and oral and gut microbiota in the development of colorectal cancer
10.3390/nu12030625 · 2020 · External reference
A cocoa (Theobroma cacao L.) extract impairs the growth, virulence properties, and inflammatory potential of Fusobacterium nucleatum and improves oral epithelial barrier function
10.1371/journal.pone.0252029 · 2021 · External reference
Taking SCFAs produced by Lactobacillus reuteri orally reshapes gut microbiota and elicits antitumor responses
10.1186/s12951-024-02506-4 · 2024 · External reference
Bifidobacterium inhibits the progression of colorectal tumorigenesis in mice through fatty acid isomerization and gut microbiota modulation
10.1080/19490976.2025.2464945 · 2025 · External reference
Vitamin D and colorectal cancer: Chemopreventive perspectives through the gut microbiota and the immune system
10.1002/biof.1786 · 2022 · External reference
Research progress on the correlation between vitamin D and colorectal cancer: opportunities and challenges
10.1097/js9.0000000000003869 · 2026 · External reference
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients
10.1016/j.neo.2022.100842 · 2022 · External reference
Vitamin D inhibits the development of colorectal cancer cells by regulating the gut microbiota and immune microenvironment using JAKSTAT signaling pathway
10.1080/08923973.2026.2630162 · 2026 · External reference
Serum vitamin D concentration, vitamin D-related polymorphisms, and colorectal cancer risk
10.1002/ijc.34521 · 2023 · External reference
Associations of vitamin D status with colorectal cancer risk and survival
10.1002/ijc.33580 · 2021 · External reference
Bidirectional Mendelian randomisation analysis of the relationship between circulating vitamin D concentration and colorectal cancer risk
10.1002/ijc.33779 · 2022 · External reference
Biochemical and metabolical pathways associated with microbiota-derived butyrate in colorectal cancer and omega-3 fatty acids implications: A narrative review
10.3390/nu14061152 · 2022 · External reference
Insight into the effects of Omega-3 fatty acids on gut microbiota: impact of a balanced tissue Omega-6/Omega-3 ratio
10.3389/fnut.2025.1575323 · 2025 · External reference
Omega-3 polyunsaturated fatty acids, gut microbiota, microbial metabolites, and risk of colorectal adenomas
10.3390/cancers14184443 · 2022 · External reference
Inverse association between eicosapentaenoic acid and incident colorectal cancer: a dose-response meta-analysis of twenty-six independent prospective cohorts
10.1007/s00394-025-03739-1 · 2025 · External reference
Colorectal 15-lipoxygenase-1 as a host factor determining the effects of eicosapentaenoic acid and docosahexaenoic acid on colorectal tumorigenesis in mice
10.1016/j.jcmgh.2025.101607 · 2025 · External reference
Omega-3 fatty acid DHA induces ferroptosis in colorectal cancer patient-derived organoids and drug-tolerant cells
10.1038/s41419-026-08744-8 · 2026 · External reference
Fatty acids and colorectal cancer: Insights from Mendelian randomization
10.1097/md.0000000000041768 · 2025 · External reference
Dietary factors modulating colorectal carcinogenesis
10.3390/nu13010143 · 2021 · External reference
Dietary selenium protects adiponectin knockout mice against chronic inflammation induced colon cancer
10.1080/15384047.2016.1276130 · 2017 · External reference
Mannose coated selenium nanoparticles normalize intestinal homeostasis in mice and mitigate colitis by inhibiting NF-κB activation and enhancing glutathione peroxidase expression
10.1186/s12951-024-02861-2 · 2024 · External reference
Effects of fecal microbiota transplantation combined with selenium on intestinal microbiota in mice with colorectal cancer
10.1016/j.bbrc.2024.150580 · 2024 · External reference
Selenium dietary intake and survival among CRC patients
10.1024/0300-9831/a000768 · 2023 · External reference
Role of dietary nutrients and metabolism in colorectal cancer
10.6133/apjcn.202406_33(2).0002 · 2024 · External reference
Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion
10.1016/j.jnutbio.2007.02.005 · 2008 · External reference
Impact of antibiotic-induced depletion of gut microbiota and selenium supplementation on plasma selenoproteome and metal homeostasis in a mice model
10.1021/acs.jafc.1c02622 · 2021 · External reference
Associations between diet and nutritional supplements and colorectal cancer: A systematic review
10.1002/jgh3.13108 · 2024 · External reference
Do sunlight and vitamin D reduce the likelihood of colon cancer
10.1093/ije/9.3.227 · 1980 · External reference
Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men
10.1016/s0140-6736(85)91082-7 · 1985 · External reference
Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study
10.1016/s0140-6736(89)91789-3 · 1989 · External reference
Serum selenium and subsequent risk of cancer among Finnish men and women
10.1093/jnci/82.10.864 · 1990 · External reference
Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis
1991 · External reference
Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group
10.1001/jama.1996.03540240035027 · 1996 · External reference
Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men
10.1023/a:1018450531136 · 1997 · External reference
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men
10.1093/jnci/djj101 · 2006 · External reference
Marine ω-3 polyunsaturated fatty acid intake and risk of colorectal cancer characterized by tumor-infiltrating T cells
10.1001/jamaoncol.2016.0605 · 2016 · External reference
Marine ω-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis
10.1136/gutjnl-2016-311990 · 2017 · External reference
Genomic profiling of active vitamin D colonic responses in African- and European-Americans identifies an ancestry-related regulatory variant of POLB
10.1371/journal.pgen.1011983 · 2026 · External reference
The role of omega-3 polyunsaturated fatty acid supplementation in postoperative recovery of colorectal cancer: systematic review and meta-analysis
10.3390/nu18010173 · 2026 · External reference
Ideal cardiovascular health in colorectal cancer patients at diagnosis
10.1016/j.clcc.2025.10.001 · 2026 · External reference
The effect of comorbidities on outcomes in colorectal cancer survivors: a population-based cohort study
10.1007/s11764-018-0710-z · 2018 · External reference
Dietary glycine prevents FOLFOX chemotherapy-induced heart injury: a colorectal cancer liver metastasis treatment model in rats
10.3390/nu12092634 · 2020 · External reference
Mediterranean diet as a therapeutic strategy for hypertension and cardiovascular health
10.1155/ijhy/2369674 · 2025 · External reference
Medicinal plant-rich diet: a potential therapeutic role in colorectal cancer
10.2174/1871525722666230915103747 · 2024 · External reference
Risk factors and prevention of cancer and CVDs: a chicken and egg situation
10.3390/jcm14093083 · 2025 · External reference
5-fluorouracil loaded prebiotic-probiotic liposomes modulating gut microbiota for improving colorectal cancer chemotherapy
10.1002/adhm.202403587 · 2025 · External reference
5-fluorouracil-related cardiotoxicity with coronary vasospasms
10.55729/2000-9666.1094 · 2022 · External reference
Managing life-threatening 5-fluorouracil cardiotoxicity
10.1136/bcr-2022-251016 · 2022 · External reference
Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm
2019 · External reference
The prevalence of 5-fluorouracil and capecitabine cardiotoxicity: A systematic review and meta-analysis
10.14740/wjon1920 · 2024 · External reference
Diagnosis and management of a patient with 5-fluorouracil-induced ST elevation and nonsustained ventricular tachycardia as a late presentation of cardiotoxicity and successful 5-fluorouracil rechallenge
10.7759/cureus.30489 · 2022 · External reference
Microbial metabolite sodium butyrate enhances the anti-tumor efficacy of 5-fluorouracil against colorectal cancer by modulating PINK1/Parkin signaling and intestinal flora
10.1038/s41598-024-63993-x · 2024 · External reference
Gut microbiota metabolites positively impacts chemotherapy effects in colorectal cancer
10.1007/s10565-026-10147-6 · 2026 · External reference
A case of ventricular arrhythmia in a patient with HER2-positive gastric cancer receiving trastuzumab
10.1155/crgm/2752788 · 2025 · External reference
Case report: Coronary vasospasm precipitating STEMI and polymorphic ventricular tachycardia-a case of cardiotoxicity from 5-FU based chemotherapy in a 41-year-old woman
10.3389/fcvm.2025.1594338 · 2025 · External reference
Alternative treatment options in patients with colorectal cancer who encounter fluoropyrimidine-induced cardiotoxicity
10.2147/ott.s264156 · 2020 · External reference
Huang-Lian-Jie-Du decoction enhances capecitabine-oxaliplatin efficacy via Akkermansia muciniphila and CD8(+) T cells in colorectal cancer
10.1016/j.phymed.2025.157233 · 2025 · External reference
Improving cardiac resilience to ischemia/reperfusion: The role of butyrate in mitochondrial and metabolic recovery
10.1016/j.atherosclerosis.2026.120669 · 2026 · External reference
Cardiovascular adverse events of antineoplastic monoclonal antibodies among cancer patients: Real-world evidence from a tertiary healthcare system
10.1186/s40959-023-00184-z · 2023 · External reference
Cardiovascular toxicity of targeted therapies for cancer: An overview of systematic reviews
10.1093/jncics/pkaa076 · 2020 · External reference
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
10.1038/nrd1381 · 2004 · External reference
Mechanisms of VEGF (vascular endothelial growth factor) inhibitor-associated hypertension and vascular disease
10.1161/hypertensionaha.117.10271 · 2018 · External reference
Targeting gut microbiota to treat hypertension: A systematic review
10.3390/ijerph18031248 · 2021 · External reference
The intersection of colorectal cancer and cardiovascular disease: Shared mechanisms and clinical implications
10.1007/s12094-026-04367-9 · 2026 · External reference
Gut microbiota-derived short-chain fatty acids facilitate microbiota:Host cross talk and modulate obesity and hypertension
10.1007/s11906-020-01125-2 · 2021 · External reference
Increases in circulating and fecal butyrate are associated with reduced blood pressure and hypertension: Results from the SPIRIT trial
10.1161/jaha.121.024763 · 2022 · External reference
Effects of oral butyrate on blood pressure in patients with hypertension: A randomized, placebo-controlled trial
10.1161/hypertensionaha.123.22437 · 2024 · External reference
Cold exposure, gut microbiota, and hypertension: A mechanistic study
10.1016/j.scitotenv.2022.155199 · 2022 · External reference
Enhancing colorectal cancer treatment: The role of Bifidobacterium in modulating gut immunity and mitigating capecitabine-induced toxicity
10.1002/mnfr.70023 · 2025 · External reference
Inflammatory fibroblasts make rectal cancer resistant to radiation therapy
10.1016/j.ccell.2022.01.005 · 2022 · External reference
Care of cancer survivors: Special issues for colorectal cancer survivors
2023 · External reference
Predictive factors of response in lung metastases treated by sbrt from colon rectal cancer
10.1007/s10585-026-10402-4 · 2026 · External reference
Invisible foes: How air pollution and lifestyle conspire in the rise of colorectal cancer
10.1093/qjmed/hcaf074 · 2025 · External reference
Tolerability on serious adverse events of first-line bevacizumab and cetuximab for RAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis
10.3390/healthcare10020217 · 2022 · External reference
Safety assessment on serious adverse events of targeted therapeutic agents prescribed for RAS wild-type metastatic colorectal cancer: Systematic review and network meta-analysis
10.3390/ijerph19159196 · 2022 · External reference
Anti-PD-1 and regorafenib induce severe multisystem adverse events in microsatellite stability metastatic colorectal cancer: A case report
10.2217/imt-2020-0327 · 2021 · External reference
Acetylcholine receptor binding antibody-associated myasthenia gravis, myocarditis, and rhabdomyolysis induced by tislelizumab in a patient with colon cancer: A case report and literature review
10.3389/fonc.2022.1053370 · 2022 · External reference
Microbiota effect on trimethylamine N-oxide production: From cancer to fitness-a practical preventing recommendation and therapies
10.3390/nu15030563 · 2023 · External reference
Gut microbiota in atherosclerosis: Focus on trimethylamine N-oxide
10.1111/apm.13038 · 2020 · External reference
The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review
10.17305/bb.2023.8893 · 2023 · External reference
Protective effect of microbiota-derived short chain fatty acids on vascular dysfunction in mice with systemic lupus erythematosus induced by toll like receptor 7 activation
10.1016/j.phrs.2023.106997 · 2023 · External reference
Protective effects of short-chain fatty acids on endothelial dysfunction induced by angiotensin II
10.3389/fphys.2020.00277 · 2020 · External reference
Assessment of the safety and probiotic properties of Roseburia intestinalis: A potential "Next Generation Probiotic
10.3389/fmicb.2022.973046 · 2022 · External reference
Cardiac function of colorectal cancer mice is remotely controlled by gut microbiota: Regulating serum metabolites and myocardial cytokines
10.1186/s42523-025-00405-z · 2025 · External reference
The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease
10.1038/s41569-022-00771-0 · 2023 · External reference
Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health
10.1080/19490976.2020.1748261 · 2020 · External reference
Bile acids regulate cardiovascular function
10.1111/j.1752-8062.2011.00272.x · 2011 · External reference
Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy
10.1038/s42255-024-01036-5 · 2024 · External reference
Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism
10.1016/j.jare.2024.06.028 · 2025 · External reference
Potential far-reaching metabolic consequences of cholecystectomy
10.1111/eci.70198 · 2026 · External reference
Gut microbiota and diet in colorectal cancer: Converging determinants of carcinogenesis
10.1080/19490976.2026.2664684 · 2026 · External reference
Gut microbiota and colorectal cancer: Mechanistic insights, diagnostic advances, and microbiome-based therapeutic strategies
10.3389/fmicb.2025.1699893 · 2025 · External reference
Advances in drug resistance and resistance mechanisms of four colorectal cancer-associated gut microbiota
10.7717/peerj.19535 · 2025 · External reference
Pathophysiology of sepsis-induced cardiomyopathy
10.1038/s41569-020-00492-2 · 2021 · External reference
Fusobacterium nucleatum secretes outer membrane vesicles and promotes intestinal inflammation
10.1128/mbio.02706-20 · 2021 · External reference
Toll-like receptor 4 inflammatory perspective on doxorubicin-induced cardiotoxicity
10.3390/molecules28114294 · 2023 · External reference
Effect of gut flora mediated-bile acid metabolism on intestinal immune microenvironment
10.1111/imm.13672 · 2023 · External reference
Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases
10.1038/s41423-021-00661-4 · 2021 · External reference
Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses
10.3389/fmicb.2023.1126808 · 2023 · External reference
Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities
10.3389/fimmu.2026.1757513 · 2026 · External reference
Sodium butyrate modulates gut microbiota and immune response in colorectal cancer liver metastatic mice
10.1007/s10565-020-09518-4 · 2020 · External reference
Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota
10.18632/aging.203914 · 2022 · External reference
Myocardial milieu favors local differentiation of regulatory T cells
10.1161/circresaha.122.322183 · 2023 · External reference
Fusobacterium nucleatum infection activates the noncanonical inflammasome and exacerbates inflammatory response in DSS-induced colitis
10.1002/eji.202350455 · 2023 · External reference
The NLRP3 inflammasome: Mechanism of action, role in disease and therapies
10.1016/j.mam.2020.100889 · 2020 · External reference
The role of Fusobacterium nucleatum in the pathogenesis of colon cancer
10.1177/10815589241277829 · 2024 · External reference
Cancer therapy-induced cardiotoxicity: mechanisms and mitigations
10.1007/s10741-025-10531-0 · 2025 · External reference
Importance of dietary fibre, strategies for increasing intake and maintenance of the supply chain in the UK
10.1098/rstb.2024.0148 · 2025 · External reference
Gut microbiome: profound implications for diet and disease
10.3390/nu11071613 · 2019 · External reference
Metabolic dysbiosis of the gut microbiota and its biomarkers
2016 · External reference
Exploring the nexus: Clinical and physiological correlation between cardiovascular disease and colorectal cancer
10.1113/ep092898 · 2026 · External reference
Molecular identification and selection of probiotic strains able to reduce the serum TMAO level in mice challenged with choline
10.3390/foods10122931 · 2021 · External reference
Association between probiotic, prebiotic, and yogurt consumption and colorectal cancer: real-world evidence from the US NHANES
10.1038/s41387-026-00432-y · 2026 · External reference
Fungal β-Glucans: Biological properties, immunomodulatory effects, diagnostic and therapeutic applications
10.36519/idcm.2025.448 · 2025 · External reference
Gut microbiota-derived metabolites in colorectal cancer: The bad and the challenges
10.3389/fonc.2021.739648 · 2021 · External reference
Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: Inflammation mechanism, clinical prognostic, and potential as a therapeutic target
10.3389/fphar.2019.01360 · 2019 · External reference
Cardiovascular risk of dietary trimethylamine oxide precursors and the therapeutic potential of resveratrol and its derivatives
10.1002/2211-5463.13762 · 2024 · External reference
Crosstalk between resveratrol and gut barrier: A review
10.3390/ijms232315279 · 2022 · External reference
Gut microbiota-mediated inflammation and gut permeability in patients with obesity and colorectal cancer
10.3390/ijms21186782 · 2020 · External reference
Butyric acid ameliorates myocardial fibrosis by regulating M1/M2 polarization of macrophages and promoting recovery of mitochondrial function
10.3389/fnut.2022.875473 · 2022 · External reference
Recent advancements and comprehensive analyses of butyric acid in cardiovascular diseases
10.3389/fcvm.2025.1608658 · 2025 · External reference
The role of fecal microbiota transplantation in the allogeneic stem cell transplant setting
10.3390/microorganisms11092182 · 2023 · External reference
Exploring the gut microbiome's influence on cancer-associated anemia: Mechanisms, clinical challenges, and innovative therapies
10.4292/wjgpt.v16.i2.105375 · 2025 · External reference
Roseburia intestinalis sensitizes colorectal cancer to radiotherapy through the butyrate/OR51E1/RALB axis
10.1016/j.celrep.2024.113846 · 2024 · External reference
Gut microbiota as a hidden modulator of chemotherapy: implications for colorectal cancer treatment
10.1007/s12672-025-03574-0 · 2025 · External reference
Association of polygenic risk score and bacterial toxins at screening colonoscopy with colorectal cancer progression: A multicenter case-control study
10.3390/toxins13080569 · 2021 · External reference
Therapeutic potential of fecal microbiota transplantation in colorectal cancer based on gut microbiota regulation: from pathogenesis to efficacy
10.1177/17562848251327167 · 2025 · External reference
Human fecal transplantation modifies the gut microbiota but not metabolites in colon cancer patient-derived xenografts
10.3390/ijms27031438 · 2026 · External reference
Butyrate receptor HCAR2/GPR109A controls imiquimod-induced psoriasis-like skin inflammation
10.1093/jimmun/vkaf069 · 2025 · External reference
Butyrate suppresses atherosclerotic inflammation by regulating macrophages and polarization via GPR43/HDAC-miRNAs axis in ApoE-/- mice
10.1371/journal.pone.0282685 · 2023 · External reference
Gut microbiota Eubacterium callanderi exerts anti-colorectal cancer activity
10.1128/spectrum.02531-22 · 2022 · External reference
Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion
10.1038/s41467-021-25965-x · 2021 · External reference
Identification of clinically relevant profiles in colorectal cancer through integrated analysis of bacterial DNA and metabolome in serum
10.3389/fimmu.2025.1562416 · 2025 · External reference
Identification of host gene-microbiome associations in colorectal cancer patients using mendelian randomization
10.1186/s12967-023-04335-9 · 2023 · External reference
Multi-omics mechanical analysis of gut microbiota, carboxylic acids, and cardiac gene expression interaction triggering diabetic cardiomyopathy
10.1128/msystems.01450-24 · 2025 · External reference
Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group
10.1001/jama.1996.03540240035027 · ExternalCitation · doi-reference
Marine ω-3 polyunsaturated fatty acid intake and risk of colorectal cancer characterized by tumor-infiltrating T cells
10.1001/jamaoncol.2016.0605 · ExternalCitation · doi-reference
Cardiovascular risk of dietary trimethylamine oxide precursors and the therapeutic potential of resveratrol and its derivatives
10.1002/2211-5463.13762 · ExternalCitation · doi-reference
5-fluorouracil loaded prebiotic-probiotic liposomes modulating gut microbiota for improving colorectal cancer chemotherapy
10.1002/adhm.202403587 · ExternalCitation · doi-reference
Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer
10.1002/advs.202205563 · ExternalCitation · doi-reference
Male-biased gut microbiome and metabolites aggravate colorectal cancer development
10.1002/advs.202206238 · ExternalCitation · doi-reference
Vitamin D and colorectal cancer: Chemopreventive perspectives through the gut microbiota and the immune system
10.1002/biof.1786 · ExternalCitation · doi-reference
Impeding quorum sensing among the intestinal microbiota impacts the metastatic rate of colorectal cancer
10.1002/cam4.71009 · ExternalCitation · doi-reference
Fusobacterium nucleatum infection activates the noncanonical inflammasome and exacerbates inflammatory response in DSS-induced colitis
10.1002/eji.202350455 · ExternalCitation · doi-reference
Association of anti-inflammatory dietary adherence with biomarkers and gut microbiota related to colorectal cancer risk: A retrospective study
10.1002/fsn3.71497 · ExternalCitation · doi-reference
Chronic antibiotic use, gut microbiota dysbiosis, and increased risk of colorectal cancer: An emerging threat
10.1002/hsr2.71866 · ExternalCitation · doi-reference
Associations of vitamin D status with colorectal cancer risk and survival
10.1002/ijc.33580 · ExternalCitation · doi-reference
Bidirectional Mendelian randomisation analysis of the relationship between circulating vitamin D concentration and colorectal cancer risk
10.1002/ijc.33779 · ExternalCitation · doi-reference
Serum vitamin D concentration, vitamin D-related polymorphisms, and colorectal cancer risk
10.1002/ijc.34521 · ExternalCitation · doi-reference
Associations between diet and nutritional supplements and colorectal cancer: A systematic review
10.1002/jgh3.13108 · ExternalCitation · doi-reference
Enhancing colorectal cancer treatment: The role of Bifidobacterium in modulating gut immunity and mitigating capecitabine-induced toxicity
10.1002/mnfr.70023 · ExternalCitation · doi-reference
Inverse association between eicosapentaenoic acid and incident colorectal cancer: a dose-response meta-analysis of twenty-six independent prospective cohorts
10.1007/s00394-025-03739-1 · ExternalCitation · doi-reference
Gut microbiota-derived metabolites in CRC progression and causation
10.1007/s00432-021-03729-w · ExternalCitation · doi-reference
Enterotoxigenic Bacteroides fragilis (ETBF) enhances colorectal cancer cell proliferation and metastasis through HDAC3/miR-139-3p pathway
10.1007/s10528-023-10621-4 · ExternalCitation · doi-reference
Sodium butyrate modulates gut microbiota and immune response in colorectal cancer liver metastatic mice
10.1007/s10565-020-09518-4 · ExternalCitation · doi-reference
Gut microbiota metabolites positively impacts chemotherapy effects in colorectal cancer
10.1007/s10565-026-10147-6 · ExternalCitation · doi-reference
Predictive factors of response in lung metastases treated by sbrt from colon rectal cancer
10.1007/s10585-026-10402-4 · ExternalCitation · doi-reference
Cancer therapy-induced cardiotoxicity: mechanisms and mitigations
10.1007/s10741-025-10531-0 · ExternalCitation · doi-reference
Polysaccharide of Danggui Buxue Decoction attenuates colorectal cancer via modulating intestinal microflora and metabolites
10.1007/s11655-025-3833-x · ExternalCitation · doi-reference
The effect of comorbidities on outcomes in colorectal cancer survivors: a population-based cohort study
10.1007/s11764-018-0710-z · ExternalCitation · doi-reference
Gut microbiota-derived short-chain fatty acids facilitate microbiota:Host cross talk and modulate obesity and hypertension
10.1007/s11906-020-01125-2 · ExternalCitation · doi-reference
Exploring the role of gut microbiome in colon cancer
10.1007/s12010-021-03498-9 · ExternalCitation · doi-reference
The intersection of colorectal cancer and cardiovascular disease: Shared mechanisms and clinical implications
10.1007/s12094-026-04367-9 · ExternalCitation · doi-reference
Effect of gut microbiota in the colorectal cancer and potential target therapy
10.1007/s12672-022-00517-x · ExternalCitation · doi-reference
Diversity in gut microbiota among colorectal cancer patients: Findings from a case-control study conducted at a Tunisian University Hospital
10.1007/s12672-024-01232-5 · ExternalCitation · doi-reference
Short-chain fatty acids play a positive role in colorectal cancer
10.1007/s12672-024-01313-5 · ExternalCitation · doi-reference
Gut microbiota as a hidden modulator of chemotherapy: implications for colorectal cancer treatment
10.1007/s12672-025-03574-0 · ExternalCitation · doi-reference
Dietary manipulation on gut microbiome in patients with diabetes and colorectal cancer
10.1007/s13668-025-00667-8 · ExternalCitation · doi-reference
Microbiota-associated mechanisms in colorectal cancer
10.1016/bs.adgen.2024.05.002 · ExternalCitation · doi-reference
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
10.1016/j.annonc.2019.10.023 · ExternalCitation · doi-reference
Improving cardiac resilience to ischemia/reperfusion: The role of butyrate in mitochondrial and metabolic recovery
10.1016/j.atherosclerosis.2026.120669 · ExternalCitation · doi-reference
Research progress on gut microbiota in colorectal cancer immunotherapy
10.1016/j.bbcan.2025.189476 · ExternalCitation · doi-reference
Effects of fecal microbiota transplantation combined with selenium on intestinal microbiota in mice with colorectal cancer
10.1016/j.bbrc.2024.150580 · ExternalCitation · doi-reference
A novel radio-immunotherapy strategy: Gut microbiota metabolite combined with radioactive hydrogel for the treatment of low rectal cancer
10.1016/j.biomaterials.2025.123386 · ExternalCitation · doi-reference
Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation
10.1016/j.canlet.2021.11.027 · ExternalCitation · doi-reference
Gut microbiota and colorectal cancer metastasis
10.1016/j.canlet.2022.216039 · ExternalCitation · doi-reference
Inflammatory fibroblasts make rectal cancer resistant to radiation therapy
10.1016/j.ccell.2022.01.005 · ExternalCitation · doi-reference
Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer
10.1016/j.ccell.2022.11.013 · ExternalCitation · doi-reference
Roseburia intestinalis sensitizes colorectal cancer to radiotherapy through the butyrate/OR51E1/RALB axis
10.1016/j.celrep.2024.113846 · ExternalCitation · doi-reference
Ideal cardiovascular health in colorectal cancer patients at diagnosis
10.1016/j.clcc.2025.10.001 · ExternalCitation · doi-reference
Characterization of the gut microbiota in patients with stage III colorectal cancer: A case-control study
10.1016/j.gene.2025.149913 · ExternalCitation · doi-reference
Ginseng polysaccharides ameliorate colorectal tumorigenesis through Lachnospiraceae-mediated immune modulation
10.1016/j.ijbiomac.2025.142015 · ExternalCitation · doi-reference
Dietary modulation of gut microbiota in patients with colorectal cancer undergoing surgery: A review
10.1016/j.ijsu.2022.106751 · ExternalCitation · doi-reference
Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice
10.1016/j.intimp.2020.106862 · ExternalCitation · doi-reference
AC1Q3QWB inhibits colorectal cancer progression by modulating the immune response and balancing the structure of the intestinal microbiota
10.1016/j.intimp.2023.109768 · ExternalCitation · doi-reference
Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism
10.1016/j.jare.2024.06.028 · ExternalCitation · doi-reference
Oxaliplatin-induced acquired long QT syndrome with torsades de pointes and myocardial injury in a patient with dilated cardiomyopathy and rectal cancer
10.1016/j.jcma.2013.05.001 · ExternalCitation · doi-reference
Colorectal 15-lipoxygenase-1 as a host factor determining the effects of eicosapentaenoic acid and docosahexaenoic acid on colorectal tumorigenesis in mice
10.1016/j.jcmgh.2025.101607 · ExternalCitation · doi-reference
Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion
10.1016/j.jnutbio.2007.02.005 · ExternalCitation · doi-reference
The NLRP3 inflammasome: Mechanism of action, role in disease and therapies
10.1016/j.mam.2020.100889 · ExternalCitation · doi-reference
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients
10.1016/j.neo.2022.100842 · ExternalCitation · doi-reference
Downregulation of the farnesoid X receptor promotes colorectal tumorigenesis by facilitating enterotoxigenic Bacteroides fragilis colonization
10.1016/j.phrs.2022.106101 · ExternalCitation · doi-reference
Protective effect of microbiota-derived short chain fatty acids on vascular dysfunction in mice with systemic lupus erythematosus induced by toll like receptor 7 activation
10.1016/j.phrs.2023.106997 · ExternalCitation · doi-reference
Huang-Lian-Jie-Du decoction enhances capecitabine-oxaliplatin efficacy via Akkermansia muciniphila and CD8(+) T cells in colorectal cancer
10.1016/j.phymed.2025.157233 · ExternalCitation · doi-reference
Zhenqi Fuzheng Granule targets the SCFAs-GPR109A axis to enhance PD-1 antibody efficacy via immunometabolic remodeling in colorectal cancer
10.1016/j.phymed.2025.157312 · ExternalCitation · doi-reference
Implications of hydrogen sulfide in colorectal cancer: Mechanistic insights and diagnostic and therapeutic strategies
10.1016/j.redox.2023.102601 · ExternalCitation · doi-reference
Cold exposure, gut microbiota, and hypertension: A mechanistic study
10.1016/j.scitotenv.2022.155199 · ExternalCitation · doi-reference
Colorectal cancer occurrence and treatment based on changes in intestinal flora
10.1016/j.semcancer.2020.05.004 · ExternalCitation · doi-reference
Physiological drivers of pks+ E. coli in colorectal cancer
10.1016/j.tim.2025.04.010 · ExternalCitation · doi-reference
Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men
10.1016/s0140-6736(85)91082-7 · ExternalCitation · doi-reference
Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study
10.1016/s0140-6736(89)91789-3 · ExternalCitation · doi-reference
Impact of antibiotic-induced depletion of gut microbiota and selenium supplementation on plasma selenoproteome and metal homeostasis in a mice model
10.1021/acs.jafc.1c02622 · ExternalCitation · doi-reference
Resistant starch nanoparticles induce colitis through lysosomal exocytosis in mice
10.1021/acsnano.4c10481 · ExternalCitation · doi-reference
Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men
10.1023/a:1018450531136 · ExternalCitation · doi-reference
Selenium dietary intake and survival among CRC patients
10.1024/0300-9831/a000768 · ExternalCitation · doi-reference
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
10.1038/nrd1381 · ExternalCitation · doi-reference
Association between probiotic, prebiotic, and yogurt consumption and colorectal cancer: real-world evidence from the US NHANES
10.1038/s41387-026-00432-y · ExternalCitation · doi-reference
Intratumoral presence of the genotoxic gut bacteria pks(+) E. coli, enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer
10.1038/s41416-023-02554-x · ExternalCitation · doi-reference
Gut microbiota-associated predictors as biomarkers of neoadjuvant treatment response in rectal cancer-a systematic review
10.1038/s41416-026-03443-9 · ExternalCitation · doi-reference
Omega-3 fatty acid DHA induces ferroptosis in colorectal cancer patient-derived organoids and drug-tolerant cells
10.1038/s41419-026-08744-8 · ExternalCitation · doi-reference
Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases
10.1038/s41423-021-00661-4 · ExternalCitation · doi-reference
Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion
10.1038/s41467-021-25965-x · ExternalCitation · doi-reference
Harnessing gut microbiota for colorectal cancer therapy: From clinical insights to therapeutic innovations
10.1038/s41522-025-00818-3 · ExternalCitation · doi-reference
Gut microbiome-driven colorectal cancer via immune, metabolic, neural, and endocrine axes reprogramming
10.1038/s41522-025-00883-8 · ExternalCitation · doi-reference
Pathophysiology of sepsis-induced cardiomyopathy
10.1038/s41569-020-00492-2 · ExternalCitation · doi-reference
The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease
10.1038/s41569-022-00771-0 · ExternalCitation · doi-reference
Consequences of ionizing radiation exposure to the cardiovascular system
10.1038/s41569-024-01056-4 · ExternalCitation · doi-reference
Gut microbiota in colorectal cancer development and therapy
10.1038/s41571-023-00766-x · ExternalCitation · doi-reference
Microbial metabolite sodium butyrate enhances the anti-tumor efficacy of 5-fluorouracil against colorectal cancer by modulating PINK1/Parkin signaling and intestinal flora
10.1038/s41598-024-63993-x · ExternalCitation · doi-reference
Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy
10.1038/s42255-024-01036-5 · ExternalCitation · doi-reference
Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression
10.1038/s42255-024-01191-9 · ExternalCitation · doi-reference
Tea polyphenols inhibit the growth and virulence properties of Fusobacterium nucleatum
10.1038/srep44815 · ExternalCitation · doi-reference
Integrated gut microbiome and metabolome analysis reveals the inhibition effect of Lactobacillus plantarum CBT against colorectal cancer
10.1039/d3fo04806c · ExternalCitation · doi-reference
Altered mycobiota signatures and enriched pathogenic Aspergillus rambellii are associated with colorectal cancer based on multicohort fecal metagenomic analyses
10.1053/j.gastro.2022.06.038 · ExternalCitation · doi-reference
High soluble fiber promotes colorectal tumorigenesis through modulating gut microbiota and metabolites in mice
10.1053/j.gastro.2023.10.012 · ExternalCitation · doi-reference
Hydrogen sulfide perturbs mitochondrial bioenergetics and triggers metabolic reprogramming in colon cells
10.1074/jbc.ra119.009442 · ExternalCitation · doi-reference
Gut microbiome as a treatment in colorectal cancer
10.1080/08830185.2024.2312294 · ExternalCitation · doi-reference
Vitamin D inhibits the development of colorectal cancer cells by regulating the gut microbiota and immune microenvironment using JAKSTAT signaling pathway
10.1080/08923973.2026.2630162 · ExternalCitation · doi-reference
Amelioration impact of gut-brain communication on obesity control by regulating gut microbiota composition through the ingestion of animal-plant-derived peptides and dietary fiber: Can food reward effect as a hidden regulator
10.1080/10408398.2023.2241078 · ExternalCitation · doi-reference
Dietary selenium protects adiponectin knockout mice against chronic inflammation induced colon cancer
10.1080/15384047.2016.1276130 · ExternalCitation · doi-reference
Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health
10.1080/19490976.2020.1748261 · ExternalCitation · doi-reference
Enterotoxigenic Bacteroides fragilis induces the stemness in colorectal cancer via upregulating histone demethylase JMJD2B
10.1080/19490976.2020.1788900 · ExternalCitation · doi-reference
Colorectal cancer and gut microbiota studies in China
10.1080/19490976.2023.2236364 · ExternalCitation · doi-reference
Fusobacterium nucleatum induces chemoresistance in colorectal cancer by inhibiting pyroptosis via the Hippo pathway
10.1080/19490976.2024.2333790 · ExternalCitation · doi-reference
Bifidobacterium inhibits the progression of colorectal tumorigenesis in mice through fatty acid isomerization and gut microbiota modulation
10.1080/19490976.2025.2464945 · ExternalCitation · doi-reference
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention
10.1080/19490976.2025.2483780 · ExternalCitation · doi-reference
Gut microbiota and diet in colorectal cancer: Converging determinants of carcinogenesis
10.1080/19490976.2026.2664684 · ExternalCitation · doi-reference
The effect of haem in red and processed meat on the endogenous formation of N-nitroso compounds in the upper gastrointestinal tract
10.1093/carcin/bgl192 · ExternalCitation · doi-reference
Do sunlight and vitamin D reduce the likelihood of colon cancer
10.1093/ije/9.3.227 · ExternalCitation · doi-reference
Butyrate receptor HCAR2/GPR109A controls imiquimod-induced psoriasis-like skin inflammation
10.1093/jimmun/vkaf069 · ExternalCitation · doi-reference
Serum selenium and subsequent risk of cancer among Finnish men and women
10.1093/jnci/82.10.864 · ExternalCitation · doi-reference
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men
10.1093/jnci/djj101 · ExternalCitation · doi-reference
Cardiovascular toxicity of targeted therapies for cancer: An overview of systematic reviews
10.1093/jncics/pkaa076 · ExternalCitation · doi-reference
Prospective associations of circulating bile acids and short-chain fatty acids with incident colorectal cancer
10.1093/jncics/pkac027 · ExternalCitation · doi-reference
Mechanisms of intestinal flora in colorectal cancer
10.1093/postmj/qgaf026 · ExternalCitation · doi-reference
Invisible foes: How air pollution and lifestyle conspire in the rise of colorectal cancer
10.1093/qjmed/hcaf074 · ExternalCitation · doi-reference
Microbe-based management for colorectal cancer
10.1097/cm9.0000000000001887 · ExternalCitation · doi-reference
Intestinal dysbiosis and colorectal cancer
10.1097/cm9.0000000000003617 · ExternalCitation · doi-reference
Research progress on the correlation between vitamin D and colorectal cancer: opportunities and challenges
10.1097/js9.0000000000003869 · ExternalCitation · doi-reference
Fatty acids and colorectal cancer: Insights from Mendelian randomization
10.1097/md.0000000000041768 · ExternalCitation · doi-reference
Importance of dietary fibre, strategies for increasing intake and maintenance of the supply chain in the UK
10.1098/rstb.2024.0148 · ExternalCitation · doi-reference
Inulin modulates gut microbiota and increases short-chain fatty acids levels to inhibit colon tumorigenesis in rat models: A systematic review and meta-analysis
10.1111/1750-3841.70250 · ExternalCitation · doi-reference
Gut microbiota in atherosclerosis: Focus on trimethylamine N-oxide
10.1111/apm.13038 · ExternalCitation · doi-reference
Potential far-reaching metabolic consequences of cholecystectomy
10.1111/eci.70198 · ExternalCitation · doi-reference
Effect of gut flora mediated-bile acid metabolism on intestinal immune microenvironment
10.1111/imm.13672 · ExternalCitation · doi-reference
Bile acids regulate cardiovascular function
10.1111/j.1752-8062.2011.00272.x · ExternalCitation · doi-reference
Cost effectiveness of colorectal cancer screening strategies in middle- and high-income countries: A systematic review
10.1111/jgh.16882 · ExternalCitation · doi-reference
Exploring the nexus: Clinical and physiological correlation between cardiovascular disease and colorectal cancer
10.1113/ep092898 · ExternalCitation · doi-reference
Fusobacterium nucleatum secretes outer membrane vesicles and promotes intestinal inflammation
10.1128/mbio.02706-20 · ExternalCitation · doi-reference
Fecal bacterial biomarkers and blood biochemical indicators as potential key factors in the development of colorectal cancer
10.1128/msystems.00043-25 · ExternalCitation · doi-reference
Targeted depletion of pks+ bacteria from a fecal microbiota using specific antibodies
10.1128/msystems.00079-23 · ExternalCitation · doi-reference
Multi-omics mechanical analysis of gut microbiota, carboxylic acids, and cardiac gene expression interaction triggering diabetic cardiomyopathy
10.1128/msystems.01450-24 · ExternalCitation · doi-reference
Gut microbiota Eubacterium callanderi exerts anti-colorectal cancer activity
10.1128/spectrum.02531-22 · ExternalCitation · doi-reference
Managing life-threatening 5-fluorouracil cardiotoxicity
10.1136/bcr-2022-251016 · ExternalCitation · doi-reference
Marine ω-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis
10.1136/gutjnl-2016-311990 · ExternalCitation · doi-reference
Production of hydrogen sulfide by the intestinal microbiota and epithelial cells and consequences for the colonic and rectal mucosa
10.1152/ajpgi.00261.2020 · ExternalCitation · doi-reference
A case of ventricular arrhythmia in a patient with HER2-positive gastric cancer receiving trastuzumab
10.1155/crgm/2752788 · ExternalCitation · doi-reference
Mediterranean diet as a therapeutic strategy for hypertension and cardiovascular health
10.1155/ijhy/2369674 · ExternalCitation · doi-reference
Gut microbiota dysbiosis drives the development of colorectal cancer
10.1159/000508328 · ExternalCitation · doi-reference
The comparison of fecal microbiota in left-side and right-side human colorectal cancer
10.1159/000516922 · ExternalCitation · doi-reference
High-fat diet-induced gut microbiota disruption promotes colorectal cancer lymphatic metastasis via propionate/GPR41 signaling
10.1159/000545843 · ExternalCitation · doi-reference
Coronary atherosclerosis in patients with cancer and survivors: A scientific statement from the American Heart Association
10.1161/cir.0000000000001391 · ExternalCitation · doi-reference
Myocardial milieu favors local differentiation of regulatory T cells
10.1161/circresaha.122.322183 · ExternalCitation · doi-reference
Mechanisms of VEGF (vascular endothelial growth factor) inhibitor-associated hypertension and vascular disease
10.1161/hypertensionaha.117.10271 · ExternalCitation · doi-reference
Effects of oral butyrate on blood pressure in patients with hypertension: A randomized, placebo-controlled trial
10.1161/hypertensionaha.123.22437 · ExternalCitation · doi-reference
Increases in circulating and fecal butyrate are associated with reduced blood pressure and hypertension: Results from the SPIRIT trial
10.1161/jaha.121.024763 · ExternalCitation · doi-reference
The role of Fusobacterium nucleatum in the pathogenesis of colon cancer
10.1177/10815589241277829 · ExternalCitation · doi-reference
Therapeutic potential of fecal microbiota transplantation in colorectal cancer based on gut microbiota regulation: from pathogenesis to efficacy
10.1177/17562848251327167 · ExternalCitation · doi-reference
Curcumin suppresses colorectal tumorigenesis through restoring the gut microbiota and metabolites
10.1186/s12885-024-12898-z · ExternalCitation · doi-reference
The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review
10.1186/s12935-021-01886-z · ExternalCitation · doi-reference
Taking SCFAs produced by Lactobacillus reuteri orally reshapes gut microbiota and elicits antitumor responses
10.1186/s12951-024-02506-4 · ExternalCitation · doi-reference
Mannose coated selenium nanoparticles normalize intestinal homeostasis in mice and mitigate colitis by inhibiting NF-κB activation and enhancing glutathione peroxidase expression
10.1186/s12951-024-02861-2 · ExternalCitation · doi-reference
Identification of host gene-microbiome associations in colorectal cancer patients using mendelian randomization
10.1186/s12967-023-04335-9 · ExternalCitation · doi-reference
BRAF(V600E) mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies
10.1186/s13046-020-01801-w · ExternalCitation · doi-reference
Prevalence of pks + bacteria and enterotoxigenic Bacteroides fragilis in patients with colorectal cancer
10.1186/s13099-022-00523-y · ExternalCitation · doi-reference
Enterotypical Prevotella and three novel bacterial biomarkers in preoperative stool predict the clinical outcome of colorectal cancer
10.1186/s40168-022-01388-8 · ExternalCitation · doi-reference
Cardiovascular adverse events of antineoplastic monoclonal antibodies among cancer patients: Real-world evidence from a tertiary healthcare system
10.1186/s40959-023-00184-z · ExternalCitation · doi-reference
Cardiac function of colorectal cancer mice is remotely controlled by gut microbiota: Regulating serum metabolites and myocardial cytokines
10.1186/s42523-025-00405-z · ExternalCitation · doi-reference
Genomic profiling of active vitamin D colonic responses in African- and European-Americans identifies an ancestry-related regulatory variant of POLB
10.1371/journal.pgen.1011983 · ExternalCitation · doi-reference
A cocoa (Theobroma cacao L.) extract impairs the growth, virulence properties, and inflammatory potential of Fusobacterium nucleatum and improves oral epithelial barrier function
10.1371/journal.pone.0252029 · ExternalCitation · doi-reference
Butyrate suppresses atherosclerotic inflammation by regulating macrophages and polarization via GPR43/HDAC-miRNAs axis in ApoE-/- mice
10.1371/journal.pone.0282685 · ExternalCitation · doi-reference
Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming
10.1371/journal.pone.0297897 · ExternalCitation · doi-reference
The prevalence of 5-fluorouracil and capecitabine cardiotoxicity: A systematic review and meta-analysis
10.14740/wjon1920 · ExternalCitation · doi-reference
The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review
10.17305/bb.2023.8893 · ExternalCitation · doi-reference
Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota
10.18632/aging.203914 · ExternalCitation · doi-reference
Advances in gut microbiota-related treatment strategies for managing colorectal cancer in humans
10.20892/j.issn.2095-3941.2024.0263 · ExternalCitation · doi-reference
Alternative treatment options in patients with colorectal cancer who encounter fluoropyrimidine-induced cardiotoxicity
10.2147/ott.s264156 · ExternalCitation · doi-reference
Gut microbiota and colorectal cancer risk factors
10.2174/1389201023666221005103340 · ExternalCitation · doi-reference
Medicinal plant-rich diet: a potential therapeutic role in colorectal cancer
10.2174/1871525722666230915103747 · ExternalCitation · doi-reference
Anti-PD-1 and regorafenib induce severe multisystem adverse events in microsatellite stability metastatic colorectal cancer: A case report
10.2217/imt-2020-0327 · ExternalCitation · doi-reference
Association analysis of the differences in intestinal flora and clinical tumor indicators among colorectal cancer patients
10.3389/fcimb.2026.1742672 · ExternalCitation · doi-reference
Case report: Coronary vasospasm precipitating STEMI and polymorphic ventricular tachycardia-a case of cardiotoxicity from 5-FU based chemotherapy in a 41-year-old woman
10.3389/fcvm.2025.1594338 · ExternalCitation · doi-reference
Recent advancements and comprehensive analyses of butyric acid in cardiovascular diseases
10.3389/fcvm.2025.1608658 · ExternalCitation · doi-reference
Potential role of the gut microbiome in colorectal cancer progression
10.3389/fimmu.2021.807648 · ExternalCitation · doi-reference
Crosstalk between gut microbiota and metastasis in colorectal cancer: Implication of neutrophil extracellular traps
10.3389/fimmu.2023.1296783 · ExternalCitation · doi-reference
Identification of clinically relevant profiles in colorectal cancer through integrated analysis of bacterial DNA and metabolome in serum
10.3389/fimmu.2025.1562416 · ExternalCitation · doi-reference
The metabolism-immune axis in colorectal cancer: Remodeling the tumor microenvironment through metabolite signaling
10.3389/fimmu.2025.1735873 · ExternalCitation · doi-reference
Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities
10.3389/fimmu.2026.1757513 · ExternalCitation · doi-reference
Assessment of the safety and probiotic properties of Roseburia intestinalis: A potential "Next Generation Probiotic
10.3389/fmicb.2022.973046 · ExternalCitation · doi-reference
The microbiome types of colorectal tissue are potentially associated with the prognosis of patients with colorectal cancer
10.3389/fmicb.2023.1100873 · ExternalCitation · doi-reference
Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses
10.3389/fmicb.2023.1126808 · ExternalCitation · doi-reference
Salivary and fecal microbiota: Potential new biomarkers for early screening of colorectal polyps
10.3389/fmicb.2023.1182346 · ExternalCitation · doi-reference
Gut microbiota and colorectal cancer: Mechanistic insights, diagnostic advances, and microbiome-based therapeutic strategies
10.3389/fmicb.2025.1699893 · ExternalCitation · doi-reference
Butyric acid ameliorates myocardial fibrosis by regulating M1/M2 polarization of macrophages and promoting recovery of mitochondrial function
10.3389/fnut.2022.875473 · ExternalCitation · doi-reference
Insight into the effects of Omega-3 fatty acids on gut microbiota: impact of a balanced tissue Omega-6/Omega-3 ratio
10.3389/fnut.2025.1575323 · ExternalCitation · doi-reference
Post-diagnostic ultra-processed food exposure in gastrointestinal cancers: scoping review with narrative synthesis and clinical implications
10.3389/fnut.2026.1884359 · ExternalCitation · doi-reference
Gut microbiota-derived metabolites in colorectal cancer: The bad and the challenges
10.3389/fonc.2021.739648 · ExternalCitation · doi-reference
Acetylcholine receptor binding antibody-associated myasthenia gravis, myocarditis, and rhabdomyolysis induced by tislelizumab in a patient with colon cancer: A case report and literature review
10.3389/fonc.2022.1053370 · ExternalCitation · doi-reference
Alterations in the gut microbiota and their metabolites in colorectal cancer: Recent progress and future prospects
10.3389/fonc.2022.841552 · ExternalCitation · doi-reference
The beneficial effect of probiotics in the prevention of irinotecan-induced diarrhea in colorectal cancer patients with colostomy: A pooled analysis of two probiotic trials (Probio-SK-003 and Probio-SK-005) led by Slovak Cooperative Oncology Group
10.3389/fonc.2024.1438657 · ExternalCitation · doi-reference
Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: Inflammation mechanism, clinical prognostic, and potential as a therapeutic target
10.3389/fphar.2019.01360 · ExternalCitation · doi-reference
Protective effects of short-chain fatty acids on endothelial dysfunction induced by angiotensin II
10.3389/fphys.2020.00277 · ExternalCitation · doi-reference
The impact of the microbiota on the immune response modulation in colorectal cancer
10.3390/biom15071005 · ExternalCitation · doi-reference
Omega-3 polyunsaturated fatty acids, gut microbiota, microbial metabolites, and risk of colorectal adenomas
10.3390/cancers14184443 · ExternalCitation · doi-reference
Association of enterotoxigenic Bacteroides fragilis with immune modulation in colorectal cancer liver metastasis
10.3390/cancers17172733 · ExternalCitation · doi-reference
Molecular identification and selection of probiotic strains able to reduce the serum TMAO level in mice challenged with choline
10.3390/foods10122931 · ExternalCitation · doi-reference
Tolerability on serious adverse events of first-line bevacizumab and cetuximab for RAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis
10.3390/healthcare10020217 · ExternalCitation · doi-reference
Targeting gut microbiota to treat hypertension: A systematic review
10.3390/ijerph18031248 · ExternalCitation · doi-reference
Safety assessment on serious adverse events of targeted therapeutic agents prescribed for RAS wild-type metastatic colorectal cancer: Systematic review and network meta-analysis
10.3390/ijerph19159196 · ExternalCitation · doi-reference
Gut microbiota-mediated inflammation and gut permeability in patients with obesity and colorectal cancer
10.3390/ijms21186782 · ExternalCitation · doi-reference
Crosstalk between resveratrol and gut barrier: A review
10.3390/ijms232315279 · ExternalCitation · doi-reference
Modulation of the tumor microenvironment by microbiota-derived short-chain fatty acids: Impact in colorectal cancer therapy
10.3390/ijms24065069 · ExternalCitation · doi-reference
Gut microbiota and colorectal cancer: A balance between risk and protection
10.3390/ijms26083733 · ExternalCitation · doi-reference
Human fecal transplantation modifies the gut microbiota but not metabolites in colon cancer patient-derived xenografts
10.3390/ijms27031438 · ExternalCitation · doi-reference
Interplay between gut microbiota and cholesterol metabolism in colorectal cancer
10.3390/ijms27062553 · ExternalCitation · doi-reference
Risk factors and prevention of cancer and CVDs: a chicken and egg situation
10.3390/jcm14093083 · ExternalCitation · doi-reference
Fecal short-chain fatty acids in colorectal cancer patients versus healthy controls: A systematic review and meta-analysis
10.3390/jcm14248949 · ExternalCitation · doi-reference
The role of fecal microbiota transplantation in the allogeneic stem cell transplant setting
10.3390/microorganisms11092182 · ExternalCitation · doi-reference
Contribution of pks+ Escherichia coli (E. coli) to colon carcinogenesis
10.3390/microorganisms12061111 · ExternalCitation · doi-reference
The obesity-related gut bacterial and viral dysbiosis can impact the risk of colon cancer development
10.3390/microorganisms8030431 · ExternalCitation · doi-reference
Toll-like receptor 4 inflammatory perspective on doxorubicin-induced cardiotoxicity
10.3390/molecules28114294 · ExternalCitation · doi-reference
Gut microbiome: profound implications for diet and disease
10.3390/nu11071613 · ExternalCitation · doi-reference
Interplay between dietary polyphenols and oral and gut microbiota in the development of colorectal cancer
10.3390/nu12030625 · ExternalCitation · doi-reference
Dietary glycine prevents FOLFOX chemotherapy-induced heart injury: a colorectal cancer liver metastasis treatment model in rats
10.3390/nu12092634 · ExternalCitation · doi-reference
Dietary factors modulating colorectal carcinogenesis
10.3390/nu13010143 · ExternalCitation · doi-reference
Biochemical and metabolical pathways associated with microbiota-derived butyrate in colorectal cancer and omega-3 fatty acids implications: A narrative review
10.3390/nu14061152 · ExternalCitation · doi-reference
Microbiota effect on trimethylamine N-oxide production: From cancer to fitness-a practical preventing recommendation and therapies
10.3390/nu15030563 · ExternalCitation · doi-reference
Gut-microbiota-derived metabolites and probiotic strategies in colorectal cancer: Implications for disease modulation and precision therapy
10.3390/nu17152501 · ExternalCitation · doi-reference
Short-chain fatty acids and colorectal cancer: A systematic review and integrative Bayesian meta-analysis of microbiome-metabolome interactions and intervention efficacy
10.3390/nu17223552 · ExternalCitation · doi-reference
The role of omega-3 polyunsaturated fatty acid supplementation in postoperative recovery of colorectal cancer: systematic review and meta-analysis
10.3390/nu18010173 · ExternalCitation · doi-reference
Microbiota-derived short-chain fatty acids: New road in colorectal cancer therapy
10.3390/pharmaceutics14112359 · ExternalCitation · doi-reference
Association of polygenic risk score and bacterial toxins at screening colonoscopy with colorectal cancer progression: A multicenter case-control study
10.3390/toxins13080569 · ExternalCitation · doi-reference
Caffeic acid phenethyl ester administration reduces enterotoxigenic Bacteroides fragilis-induced colitis and tumorigenesis
10.3390/toxins16090403 · ExternalCitation · doi-reference
Biological mechanisms of enterotoxigenic Bacteroides fragilis toxin: Linking inflammation, colorectal cancer, and clinical implications
10.3390/toxins17060305 · ExternalCitation · doi-reference
Fungal β-Glucans: Biological properties, immunomodulatory effects, diagnostic and therapeutic applications
10.36519/idcm.2025.448 · ExternalCitation · doi-reference
Gut microbiota, inflammatory bowel disease and colorectal cancer
10.3748/wjg.v28.i30.4053 · ExternalCitation · doi-reference
Calorie restriction remodels gut microbiota and suppresses tumorigenesis of colorectal cancer in mice
10.3892/etm.2022.11758 · ExternalCitation · doi-reference
Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient-derived organoids
10.3892/ijo.2020.5132 · ExternalCitation · doi-reference
Changes in gut microbiome upon orchiectomy and testosterone administration in AOM/DSS-induced colon cancer mouse model
10.4143/crt.2022.080 · ExternalCitation · doi-reference
Exploring the gut microbiome's influence on cancer-associated anemia: Mechanisms, clinical challenges, and innovative therapies
10.4292/wjgpt.v16.i2.105375 · ExternalCitation · doi-reference
Colorectal cancer and microbiota: Systematic review
10.5114/pg.2024.136228 · ExternalCitation · doi-reference
Gut microbiome diagnostic biomarkers for colorectal cancer
10.5152/tjg.2025.24810 · ExternalCitation · doi-reference
5-fluorouracil-related cardiotoxicity with coronary vasospasms
10.55729/2000-9666.1094 · ExternalCitation · doi-reference
Role of dietary nutrients and metabolism in colorectal cancer
10.6133/apjcn.202406_33(2).0002 · ExternalCitation · doi-reference
Tumor-promoting gut microbes in colorectal cancer: Mechanisms and translational perspectives
10.7150/ijms.123494 · ExternalCitation · doi-reference
Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer
10.7150/thno.54476 · ExternalCitation · doi-reference
Advances in drug resistance and resistance mechanisms of four colorectal cancer-associated gut microbiota
10.7717/peerj.19535 · ExternalCitation · doi-reference
Diagnosis and management of a patient with 5-fluorouracil-induced ST elevation and nonsustained ventricular tachycardia as a late presentation of cardiotoxicity and successful 5-fluorouracil rechallenge
10.7759/cureus.30489 · ExternalCitation · doi-reference